Scientists at the University of East Anglia are getting closer to solving the problem of antibiotic resistance.
New research published today in the journal Nature reveals the mechanism by which drug-resistant bacterial cells maintain a defensive barrier.
The findings pave the way for a new wave of drugs that kill superbugs by bringing down their defensive walls rather than attacking the bacteria itself. It means that in future, bacteria may not develop drug-resistance at all.
Unravelling this mechanism could also help scientists understand more about human cell dysfunctions linked to disorders such as diabetes, Parkinson’s and other neurodegenerative diseases.
The team, supported by the Wellcome Trust, used Diamond Light Source, one of the world’s most advanced scientific machines, to investigate a class of bacteria called ‘Gram-negative bacteria’.
Diamond produces intense light 10 billion times brighter than the sun, allowing scientists to explore almost any material in atomic detail.
Gram-negative bacteria is particularly resistant to antibiotics because of its cells’ impermeable lipid-based outer membrane.
This outer membrane acts as a defensive barrier against attacks from the human immune system and antibiotic drugs. It allows the pathogenic bacteria to survive, but removing this barrier causes the bacteria to become more vulnerable and die.
The research team previously found an ‘Achilles heel’ in this defensive barrier. But exactly how this defensive cell wall is built and maintained – the ‘assembly machinery’ – was unknown until now.
Lead researcher Prof Changjiang Dong, from UEA’s Norwich Medical School, said: “Bacterial multi-drug resistance, also known as antibiotic resistance, is a global health challenge. Many current antibiotics are becoming useless, causing hundreds of thousands of deaths each year. The number of super-bugs is increasing at an unexpected rate.
“Gram-negative bacteria is one of the most difficult ones to control because it is so resistant to antibiotics.
“All Gram-negative bacteria have a defensive cell wall. Beta-barrel proteins form the gates of the cell wall for importing nutrition and secreting important biological molecules.
“The beta-barrel assembly machinery (BAM) is responsible for building the gates (beta-barrel proteins) in the cell wall.
“Stopping the beta-barrel assembly machine from building the gates in the cell wall cause the bacteria to die.”
Scientists studied the gram-negative bacteria E.coli, in which the beta-barrel assembly machinery contains five subunits – known as BamA, BamB, BamC, BamD and BamE. They wanted to know exactly how these subunits work together to insert the outer membrane proteins into the outer membrane or cell wall.
Prof Dong said: “Our research shows the whole beta-barrel assembly machinery structures in two states – the starting and finishing states. We found that the five subunits form a ring structure and work together to perform outer membrane protein insertion using a novel rotation and insertion mechanism.
“Our work is the first to show the entire BAM complex. It paves the way for developing new-generation drugs.
The Latest on: Superbug drugs
via Google News
The Latest on: Superbug drugs
- 'Poop Transplants' Can Transmit Deadly Superbugs, FDA Warns on June 14, 2019 at 6:15 am
"Poop transplants" have shown promise in treating severe diarrhea, but now, the Food and Drug Administration (FDA) is warning that these transplants may risk spreading superbugs. The two patients, who ... […]
- FDA warns against fecal transplants after one patient contracted a drug-resistant infection and DIED on June 14, 2019 at 2:36 am
A patient has died after undergoing a fecal transplant and contracting a drug-resistant infection, the US Food and Drug Administration (FDA) said Thursday. Now, the FDA is warning that patients hoping ... […]
- Superbug gene that resists "last resort" antibiotics detected in US for the first time on June 13, 2019 at 8:12 pm
The problem is that like many other bacteria, Salmonella has developed resistance to most of those drugs. All except colistin, an antibiotic that's largely considered the last resort against ... […]
- IMB Friday Seminar Series: : Understanding and reversing the evolution of antimicrobial resistance: making superbugs less super on June 13, 2019 at 7:09 am
Klebsiella pneumoniae is an important example of how human behaviour creates such superbugs. Previously most at home in ... We are working with partners in China to characterize and understand ... […]
- Achaogen to Sell Drug Rights, Lab Equipment for $16 Million on June 7, 2019 at 12:47 pm
Achaogen Inc., a bankrupt developer of antibacterial drugs, has reached an agreement to sell most of its assets through a court-supervised auction process for $16 million in cash. The ... […]
- Drugs designed with advanced computing technologies could help tackle hospital superbugs on June 6, 2019 at 6:29 am
Hospital superbugs such as MRSA or E.coli could soon be under attack from a new generation of drugs designed with the help of advanced computing technologies from STFC and IBM Research. Superbugs are ... […]
- HARMFUL BACTERIA: Hybrid antibiotics for superbugs? on June 4, 2019 at 3:49 pm
Superbugs — the bacteria resistant to most ... have a role as the silver bullet in gram-negative bacteria to overcome drug resistance as well as extend the spectrum of existing antibiotics ... […]
- The dirt on superbugs and how we can avoid them on June 4, 2019 at 7:00 am
Superbugs are on the rise. A World Health Organisation report released in April says drug-resistant diseases could kill 10 million people a year by 2050. But how susceptible are you to being harmed by ... […]
- Sexually transmitted superbug warning as infections soar 26% in a year on June 4, 2019 at 1:47 am
Gonorrhoea diagnoses in England have risen to their highest level for 40 years and jumped 26 per cent since 2017, sparking warnings from health chiefs about the threat from drug resistant strains. ... […]
- New compound that kills antibiotic superbugs in development on June 3, 2019 at 9:32 pm
Thomas says the work is a “breakthrough” that “could lead to vital new treatments to life-threating superbugs and the growing risk posed ... coli, including the multi-drug resistant pathogen ... […]
via Bing News